Navigation Links
Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin's Lymphoma
Date:2/20/2008

ese trials served as the basis for the Company to initiate the large, registration-enabling Phase III trial designed under a special protocol assessment (SPA) with the U.S. Food and Drug Administration (FDA) of VELCADE and rituximab in patients with relapsed follicular lymphoma. The Company is on track to complete patient accrual in this Phase III trial in the first half of 2008, with final data expected in 2010. VELCADE is already approved by the FDA to treat relapsed mantle cell lymphoma (MCL). MCL is an aggressive, rapidly progressive subtype of NHL with median life expectancy for a patient with MCL, following first relapse, of one to two years.

About Non-Hodgkin's Lymphoma

NHL is the most common hematological cancer, the fifth leading cause of cancer death and the second fastest-growing form of cancer in the U.S. The prevalence of NHL in the U.S. is approximately 400,000 patients, including approximately 200,000 patients with diffuse large B-cell lymphoma, 100,000 patients with follicular and marginal zone lymphoma and 10,000 with MCL. There are approximately 54,000 new cases of NHL diagnosed in the U.S. per year, and 19,000 deaths are attributed to the disease annually.

About VELCADE

VELCADE is being co-developed by Millennium Pharmaceuticals, Inc. and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Millennium is responsible for commercialization of VELCADE in the U.S. and Janssen-Cilag is responsible for commercialization in Europe and the rest of the world. Janssen Pharmaceutical K.K. is responsible for commercialization in Japan. For a limited period of time, Millennium and Ortho Biotech Inc. are co- promoting VELCADE in the U.S. VELCADE is approved in 85 countries worldwide. More than 85,000 patients have been treated with VELCADE globally.

In the U.S., VELCADE is indicated for the treatment of patients with multiple myeloma who have received at least one prior therapy. VELCADE is also indicated for the tre
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
2. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
3. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
4. Cellectar Expands Clinical Management Team
5. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
6. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
7. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
8. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
9. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
10. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
11. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 01, 2015 ... announced the addition of the "Elemental Analysis ... ICP-MS), Nondestructive (XRD, OES)), Application (Life Sciences, Food ... Global Forecasts to 2020" report to their ... on the basis of types, technologies, and applications. ...
(Date:7/7/2015)... , June 30, 2015 ... has announced the addition of the ... to their offering. This patent ... Photoacoustic imaging is a safe, non-invasive, non-ionizing ... and represents a great alternative to traditional ...
(Date:7/7/2015)... , July 7, 2015 Sequent Medical, ... developing innovative devices for the treatment of neurovascular ... has joined its Board of Directors.   ... of medical device and healthcare industries experience.  He ... he has commercialized numerous leading-edge products.  His experience ...
Breaking Medicine Technology:Elemental Analysis (Organic, Inorganic) Market 2015 - Analysis & Global Forecasts to 2020 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 3Sequent Medical Appoints Mike Kleine to its Board of Directors 2Sequent Medical Appoints Mike Kleine to its Board of Directors 3
... SAN DIEGO, March 20, 2012  HUYA Bioscience International ... of China,s preeminent pharmacological researchers, Prof. Deyong Ye ... an international leader in supporting the global development ... Fudan University will focus on specific innovations coming ...
... Mylan Inc. (Nasdaq: MYL ) today ... final approval from the U.S. Food and Drug Administration ... Ibandronate Sodium Tablets, 150mg. This product is the generic ... treatment and prevention of osteoporosis in postmenopausal women. ...
Cached Medicine Technology:HUYA Bioscience Announces New Partnership with a High Profile Pharmaceutical Lab at Shanghai's Prestigious Fudan University 2HUYA Bioscience Announces New Partnership with a High Profile Pharmaceutical Lab at Shanghai's Prestigious Fudan University 3
(Date:7/7/2015)... ... July 07, 2015 , ... ... items, recently launched their first line of luxury smart jewelry called the Socialite™ ... expected to ship this fall. , “The Socialite collection was crafted to ...
(Date:7/7/2015)... ... July 07, 2015 , ... Owners of Green Ladies Cleaning are ... the home service category. This honor can only be gained by votes from Madison ... safety of the products and methods they use daily. Having a home cleaned with ...
(Date:7/7/2015)... ... July 07, 2015 , ... Difass USA, a modern ... pass those long, stressful days at work is knowing that there is hopefully a ... back and stress free as imagined. Planning for a vacation can be quite stressful, ...
(Date:7/7/2015)... CA (PRWEB) , ... July 07, 2015 , ... ... Business Times highlights rumors about possible facial rejuvenation that have emerged about Hillary ... former U.S. Secretary of State looks more youthful than she has in some ...
(Date:7/7/2015)... ... , ... Greatist today announced the acquisition of Blood, Sweat ... most fun activities to do with friends. , The acquisition of BSC strengthens Greatist’s ... for events, e-commerce, and brand partnerships. , “I’ve been a huge fan of Blood, ...
Breaking Medicine News(10 mins):Health News:WiseWear Unveils Luxury Smart Jewelry Line 2Health News:Environmentally-Friendly House Cleaning Company Wins Best of Madison Magazine Award 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2
... Delayed Diagnosis;,Almost Seventy Percent Report Unnecessary or Duplicative Scans , ... ... released today (at RSNA ) uncovers a host of systemic ... demand and negatively impacting patient diagnosis and care. Of those surveyed, ...
... Corporation ("Bally"),today announced that it has filed for voluntary ... filed today in the U.S. Bankruptcy,Court for the Southern ... the chapter,11 process to significantly reduce debt from its ... It expects to accomplish,these goals through either a sale ...
... Company (PRC),the leading manufacturer of Alternative and Augmented ... selected Acapela High,Quality voices to speech empower Vantage(TM) ... Smart, compact, rugged ... device for children and adults who use augmentative,communication. ...
... Decision Resources, one of the,world,s leading research ... finds that the diagnosis and drug treatment of ... remain low through 2012,particularly in rural regions. Although ... 70 percent of the prevalent Alzheimer,s disease,population in ...
... devoted to injury prevention through exercise, has created the first of its ... DVD, hosted by physical therapist Chantal Donnelly, is distributed by the lifestyle ... Relief DVD is perfect for the gift giving season. , ... Los ...
... availability of their trusted point-of-care information on the iPhone and ... ... (PRWEB) December 3, 2008 -- Lexi-Comp, Inc., a provider of ... iPhone and the iPod touch. This latest innovation enhances Lexi-Comp,s ...
Cached Medicine News:Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 2Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 3Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 4Health News:Bally Total Fitness Files for Chapter 11 Bankruptcy Protection 2Health News:Bally Total Fitness Files for Chapter 11 Bankruptcy Protection 3Health News:Accessibility: Acapela Group Voice Enables Vantage Lite Innovative AAC Dedicated Device 2Health News:Diagnosis and Drug Treatment of Alzheimer's Disease in China is Low and Will Remain Low Through 2012 2Health News:Diagnosis and Drug Treatment of Alzheimer's Disease in China is Low and Will Remain Low Through 2012 3Health News:New Strong Knees DVD Offers Knee Pain Relief from Body Insight, Inc. and Gaiam Inc. 2Health News:Lexi-Comp Databases Now Available for the iPhone™ and iPod touch 2Health News:Lexi-Comp Databases Now Available for the iPhone™ and iPod touch 3
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: